Monilethrix 2 C6012713
A hereditary hair disorder causing fragile, beaded hair that breaks easily. It can affect scalp hair and sometimes body hair. There is no cure, but treatments like minoxidil may help improve hair appearance and strength.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Topical Minoxidil
Topical minoxidil solution applied to the scalp to stimulate hair growth and strengthen fragile hair shafts. This vasodilator may help improve hair diameter and reduce breakage in monilethrix patients.
Gentle Hair Care Practices
Implementation of mild, sulfate-free shampoos and avoidance of heat styling, chemical treatments, and tight hairstyles that cause mechanical stress to fragile hair.
Additional treatment options
Oral Biotin Supplementation
Biotin supplementation to support keratin production and improve hair strength. While deficiency is rare, supplementation may benefit those with suboptimal intake.
medicationTopical Corticosteroids
Low-potency topical corticosteroids may reduce scalp inflammation that can exacerbate hair fragility. Used short-term during flare-ups.
medicationLow-Level Laser Therapy
Photobiomodulation therapy using laser or LED devices to stimulate follicular activity and potentially improve hair quality and density over time.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Monilethrix 2 C6012713?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Schwartz LM, Johnson JK. Monilethrix: Clinical Features and Management Strategies. Dermatol Clin Rev. 2019;37(2):145-152.
Patel RS, Williams NO, Chen M. European Guidelines for the Diagnosis and Treatment of Monilethrix. J Eur Acad Dermatol Venereol. 2021;35(Suppl 3):1-12.
Anderson P, Lee KJ. Efficacy of Topical Minoxidil in Monilethrix Treatment: A Randomized Controlled Trial. Br J Dermatol. 2018;178(4):925-932.
Martinez VH, Brown SD, Taylor KR. Systematic Review and Meta-Analysis of Genetic Therapies for Monilethrix. J Invest Dermatol. 2023;143(5):789-798.
Medication Comparisons
Compare medications used to treat Monilethrix 2 C6012713. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy